Article Dans Une Revue Nature Communications Année : 2013

Dendrogenin A arises from cholesterol and histamine metabolism and shows cell differentiation and anti-tumour properties.

Loubna Mhamdi
  • Fonction : Auteur
Thomas Filleron
Talal Al Saati
  • Fonction : Auteur

Résumé

We previously synthesized dendrogenin A and hypothesized that it could be a natural metabolite occurring in mammals. Here we explore this hypothesis and report the discovery of dendrogenin A in mammalian tissues and normal cells as an enzymatic product of the conjugation of 5,6α-epoxy-cholesterol and histamine. Dendrogenin A was not detected in cancer cell lines and was fivefold lower in human breast tumours compared with normal tissues, suggesting a deregulation of dendrogenin A metabolism during carcinogenesis. We established that dendrogenin A is a selective inhibitor of cholesterol epoxide hydrolase and it triggered tumour re-differentiation and growth control in mice and improved animal survival. The properties of dendrogenin A and its decreased level in tumours suggest a physiological function in maintaining cell integrity and differentiation. The discovery of dendrogenin A reveals a new metabolic pathway at the crossroads of cholesterol and histamine metabolism and the existence of steroidal alkaloids in mammals.

Fichier principal
Vignette du fichier
ncomms2835.pdf (867.96 Ko) Télécharger le fichier
Origine Publication financée par une institution
Licence

Dates et versions

inserm-00823974 , version 1 (05-12-2024)

Licence

Identifiants

Citer

Philippe de Médina, Michael R. Paillasse, Gregory Segala, Maud Voisin, Loubna Mhamdi, et al.. Dendrogenin A arises from cholesterol and histamine metabolism and shows cell differentiation and anti-tumour properties.. Nature Communications, 2013, 4, pp.1840. ⟨10.1038/ncomms2835⟩. ⟨inserm-00823974⟩
535 Consultations
158 Téléchargements

Altmetric

Partager

  • More